Free vaccine clinics available around New Mexico in August
What Happens When The Rio Grande Runs Dry?
Got Shots clinics will provide free vaccines to children regardless of insurance status. 'Disease prevention begins with vaccinations, so protect yourselves and your loved ones by staying up to date with your shots,' manager of NMDOH's immunization program Andrea Romero said in a release.
To view the current immunization requirements and a complete list of free shot clinics available in New Mexico counties, click here.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
DexCom Stock: Analyst Estimates & Ratings
DexCom, Inc. (DXCM), headquartered in San Diego, California, is a global leader in the development and manufacturing of continuous glucose monitoring (CGM) systems. The company primarily serves people with diabetes by offering advanced, real-time monitoring solutions that track glucose levels, enabling more precise and proactive diabetes management. DexCom's flagship products include the DexCom G6 and G7 systems, which provide users with continuous, non-invasive data for better glucose control. Beyond diabetes, DexCom is expanding into areas like diabetes prevention and insulin dosing optimization, positioning itself as a key player in the evolving healthcare and medical device sectors. The company has a market capitalization of $31.36 billion. More News from Barchart Why This Cannabis Penny Stock Could Be Wall Street's Next Meme Trade Breakout Apple Stock Is Gaining Momentum, Is AAPL Stock a Buy? Peter Thiel-Backed Bullish Is About to IPO. Should You Buy BLSH Stock? Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! Shares of this medical device company have gained 12.6% over the past 52 weeks, underperforming the broader S&P 500 Index ($SPX), which has gained 19% over the same period. This year, the stock has gained a modest 2.8%, while the S&P 500 index is up almost 10% year-to-date (YTD). To put this into perspective, we compare with the sector-specific iShares U.S. Medical Devices ETF (IHI). The ETF's gains have more or less aligned with DexCom's, rising by 10.3% over the past 52 weeks and 5.9% on a YTD basis. Despite DexCom's strong second-quarter results on Jul. 30, the market's reaction was not positive, as the stock price dropped a notable 9.3% the very next trading session. The company's revenue increased 15.2% year-over-year (YOY) to $1.16 billion. DexCom also received FDA clearance for the DexCom G7 15 Day CGM System. Its adjusted EPS increased 11.6% YOY to $0.48, surpassing the $0.45 figure expected by Wall Street analysts. For the fiscal year 2025, ending this December, Wall Street analysts expect DexCom's bottom line to grow by 25% YOY to $2.05 per share on a diluted basis. The company has a mixed history of surpassing consensus estimates, topping them in two of the trailing four quarters and missing them on two other occasions. Among the 25 analysts covering DexCom's stock, the consensus is a 'Strong Buy.' That's based on 20 'Strong Buy' ratings, one 'Moderate Buy' rating, and four 'Holds.' The current configuration of the ratings is slightly more bullish than two months ago, when the stock had 19 'Strong Buy' ratings. Reflecting a stable market outlook for the company, Canaccord Genuity analyst William Plovanic maintained a 'Buy' rating on the stock this month, while keeping the price target at $106. On July 31, Raymond James analyst Jayson Bedford maintained a "Strong Buy" rating, with the price target on the stock raised from $99 to $102. DexCom's mean price target of $102.60 indicates a premium of 28.3% from the current market prices. The Street-high price target of $125 implies a potential upside of 56.3%. On the date of publication, Anushka Mukherjee did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
Yahoo
24 minutes ago
- Yahoo
Got the sniffles? Here's what to know about summer colds and the COVID-19 variant called stratus
Summer heat, outdoor fun ... and cold and flu symptoms? The three may not go together in many people's minds: partly owing to common myths about germs and partly because many viruses really do have lower activity levels in the summer. But it is possible to get the sniffles — or worse — in the summer. Federal data released Friday, for example, shows COVID-19 is trending up in most states, with emergency department visits up among people of all ages. Here's what to know about summer viruses. How much are colds and flu circulating right now? The number of people seeking medical care for three key illnesses — COVID-19, flu and respiratory syncytial virus, or RSV — is currently very low, according to data from the Centers for Disease Control and Prevention. Flu is trending down and RSV has been steady. But COVID-19 is trending up in most U.S. states. Wastewater data from around the country estimates 'moderate' COVID-19 activity. CDC wastewater also shows the XFG variant — nicknamed stratus — is most common in the U.S. Stratus can cause a 'razor blade' sore throat and is considered a 'variant under monitoring' by the World Health Organization. The WHO said the variant is only marginally better at evading people's immune systems and vaccines still work against it. The expectation is that COVID-19 will eventually settle into a winter seasonal pattern like other coronaviruses, but the past few years have brought a late summer surge, said Dr. Dean Blumberg, chief of pediatric infectious diseases at University of California Davis Children's Hospital. Other viruses circulating this time of year include the one that causes 'hand, foot and mouth' disease — which has symptoms similar to a cold, plus sores and rashes — and norovirus, sometimes called the stomach flu. Do viruses spread less in the summer? Many viruses circulate seasonally, picking up as the weather cools in the fall and winter. So it's true that fewer people get stuffy noses and coughs in the summer — but cold weather itself does not cause colds. It's not just about seasonality. The other factor is our behavior, experts say. Nice weather means people are opening windows and gathering outside where it's harder for germs to spread. But respiratory viruses are still around. When the weather gets too hot and everyone heads inside for the air conditioning, doctors say they start seeing more sickness. In places where it gets really hot for a long time, summer can be cold season in its own right. 'I grew up on the East Coast and everybody gets sick in the winter,' said Dr. Frank LoVecchio, an emergency room doctor and Arizona State University researcher. 'A lot of people get sick in the summer here. Why is that? Because you spend more time indoors.' With stratus spreading, should you get another COVID-19 booster? For people who are otherwise healthy, timing is a key consideration to getting any vaccine. You want to get it a few weeks before that big trip or wedding, if that's the reason for getting boosted, doctors say. But, for most people, it may be worth waiting until the fall in anticipation of winter cases of COVID-19 really tick up. 'You want to be fully protected at the time that it's most important for you,' said Dr. Costi Sifri, of the University of Virginia Health System. People at higher risk of complications should always talk with their doctor about what is best for them, Sifri added. Older adults and those with weak immune systems may need more boosters than others, he said. Are more younger kids getting sick with COVID-19? Last month, the CDC noted emergency room visits among children younger than 4 were rising. That makes sense, Blumberg said, because many young kids are getting it for the first time or are unvaccinated. Health Secretary Robert F. Kennedy Jr. said in May that the shots would no longer be recommended for healthy kids, a decision that health experts have said lacks scientific basis. The American Academy of Pediatrics still endorses COVID-19 shots for children older than 6 months. How else can I lower my risk? The same things that help prevent colds, flu and COVID any other time of the year work in the summer, doctors say. Spend time outside when you can, wash your hands, wear a mask. And if you're sick, stay home. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. Solve the daily Crossword
Android Authority
26 minutes ago
- Android Authority
Wear OS smartwatches no longer have this leg up over the Apple Watch
Joe Maring / Android Authority TL;DR Apple is restoring blood oxygen tracking to certain US Apple Watch models via iOS and watchOS updates. The refreshed setup uses the watch to take readings but calculates and displays results on the paired iPhone. The feature was removed in January 2024 due to a patent dispute and an import ban. Apple Watch owners in the US are getting a health-tracking feature back that many thought might be gone for good. After more than a year in limbo, the blood oxygen tool is returning to the Apple smartwatch range, though not quite in the way you remember. Don't want to miss the best from Android Authority? Set us as a preferred source in Google Search to support us and make sure you never miss our latest exclusive reports, expert analysis, and much more. As Bloomberg reports, the reactivation follows a US Customs ruling and arrives as part of iOS 18.6.1 and watchOS 11.6.1. If you've got a Series 9, Series 10, or Ultra 2 model that shipped without the feature, the update lets the watch's sensors take the reading but shifts the number-crunching to your paired iPhone. You'll find the results tucked into the Respiratory section of the Health app instead of the watch's own Blood Oxygen app. Apple removed the feature from new Series 9 and Ultra 2 units sold in the US from January 18, 2024, after the US Court of Appeals allowed an import ban tied to a patent dispute with Masimo Corp. to take effect. The hardware sensor never went away, but the software was locked down, and Apple warned at the time that the legal process could drag on for a year or more. By moving part of the process off the watch, Apple has found a way to bring the readings back without breaking the rules. The update is rolling out now, just weeks before the expected debut of the Apple Watch Series 11 alongside the iPhone 17. Follow
